LATEST

Off the Wire

IN FOCUS

Nanotechnology-Enhanced Resveratrol Shows Promise in Treatment of Triple-Negative Breast Cancer

Yes, it's that kind of resveratrol--that found in red wine. But with a technical twist to ensure it's delivered properly. Triple-negative breast cancer (TNBC) is a type of...

Omega-3 Fatty Acid and Breast Cancer Prevention for Patients Hoping for Pregnancy

A pilot trial at the National Cancer Institute, conducted by the University of Kansas Cancer Center and led by Principal Investigator Lauren Nye aims to explore the...

Study Links Air Pollution to More Severe Breast Cancer Cases

A groundbreaking study has revealed a concerning connection between air pollution and the severity of breast cancer, shedding light on how our environment could be affecting our...

LEARN MORE

RESEARCH

RESEARCH

LEARN MORE

Carrick Therapeutics Launches Breast Cancer Trial for Novel Drug Combo

Carrick Therapeutics, a company focused on creating new cancer treatments, has recently started a significant study (Phase 1b/2 clinical trial) to test a combination...

Talimogene Laherparepvec in HER2-Negative Breast Cancer: A Phase Ib Study

A new clinical study at the National Cancer Institute in the U.S. is looking into a treatment method for patients with a specific type...

Continued Trial of Trilaciclib Shows Promise in Extending Survival for Triple-Negative Breast Cancer

The next phase of an important trial for metastatic triple-negative breast cancer patients is evaluating the effectiveness of trilaciclib combined with chemotherapy. This effort, officially...

The Growing Role of Advanced PET Imaging in Breast Cancer Care

Positron Emission Tomography (PET) is becoming an increasingly important tool in managing breast cancer. This shift is largely due to more PET radiotracers being...

Nanotechnology-Enhanced Resveratrol Shows Promise in Treatment of Triple-Negative Breast Cancer

Yes, it's that kind of resveratrol--that found in red wine. But with a technical twist to ensure it's delivered properly. Triple-negative breast cancer (TNBC) is...

DRUG DEVELOPMENT